PathAI

PathAI develops AI-powered technology that assists pathologists in making accurate diagnoses for cancer and other diseases. The company provides biopharmacy lab services, clinical development services, and drug/diagnostic development using machine learning on large-scale expertly annotated datasets. PathAI has raised $415-490M in total funding and offers AISight, a cloud-native digital pathology image management system that supports case and image management along with AI tools for histopathology workflows. Founded by Aditya Khosla and Andrew H Beck.